Publications by authors named "Leander Meuris"

In this study, we evaluated the effects of experimenter handling and batch effects on proteomic analyses of mucosal scrapings in pigs. We analyzed mucosal samples from twelve piglets that were fed two distinct diets. Mucosal samples were obtained from a 60 cm segment collected from the jejunum, which was divided into six equal segments.

View Article and Find Full Text PDF

Esophageal adenocarcinoma (EAC) is an aggressive cancer characterized by a high risk of relapse post-surgery. Current follow-up methods (serum carcinoembryonic antigen detection and PET-CT) lack sensitivity and reliability, necessitating a novel approach. Analyzing cell-free DNA (cfDNA) from blood plasma emerges as a promising avenue.

View Article and Find Full Text PDF
Article Synopsis
  • Aberrant embryo implantation and placentation can lead to serious pregnancy complications like preeclampsia, and current risk identification methods are not very accurate.
  • The ExPECT study aims to validate a cell-free DNA methylation strategy to diagnose preeclampsia early and identify high-risk pregnancies by analyzing blood samples over time.
  • Results showed distinct methylation patterns between healthy and affected pregnancies, with significant differences detectable as early as 12 weeks, leading to the development of promising classification models for diagnosis and prediction.
View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is a highly lethal cancer with a low 5-year survival rate, highlighting the need for effective monitoring and prognosis.
  • A systematic review analyzed 3,904 studies to investigate if N-glycomics can predict HCC risk and survival in adults with chronic liver disease, ultimately including 30 studies in the analysis.
  • The findings suggest that changes in N-glycans, particularly the Mac-2 binding protein glycosylation isomer (M2BPGi), are valuable indicators for predicting HCC development and patient prognosis.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how glycan modifications on IgG antibodies affect their role in inflammation, focusing on patients with primary Sjögren disease (SjD).
  • Researchers analyzed IgG glycosylation in 300 patients, finding lower levels of sialylation and galactosylation in those with SjD compared to asymptomatic individuals; these changes correlate with increased B cell activation and various autoantibody profiles.
  • The findings suggest that IgG Fc glycosylation could serve as a new marker for predicting disease progression, monitoring activity, and assessing lymphoma risk in SjD patients.
View Article and Find Full Text PDF
Article Synopsis
  • Komagataella phaffii, formerly known as Pichia pastoris, is widely used for producing recombinant proteins for therapeutics and food, but the original strain NRRL Y-11430 is restricted.
  • Researchers identified the NCYC 2543 strain from 1954 as a foundation for developing an open-access strain called OPENPichia, designed to enable widespread use without restrictions.
  • By modifying the HOC1 gene in NCYC 2543, the team enhanced its ability to take up DNA and improve protein secretion, providing a genome-sequenced strain and a versatile expression vector toolkit for the biotech community.
View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is a serious liver cancer with high mortality; early diagnosis is key to improving treatment options.
  • A comprehensive review of scientific literature identified serum N-glycomics, particularly alterations like increased fucosylation and branching, as promising diagnostic markers for HCC, showing strong potential with AUCs between 0.92-0.97.
  • More rigorous study designs and larger sample sizes are necessary to validate these findings before N-glycomics can be widely used in clinical settings for HCC diagnosis.
View Article and Find Full Text PDF
Article Synopsis
  • Patients with chronic hepatitis C are at risk for serious liver issues, including fibrosis and cancer, even after successful treatment, highlighting the need for ongoing monitoring.
  • Researchers analyzed glycomics-based biomarkers in serum samples from 36 HCV patients undergoing antiviral treatment to evaluate the effects on liver inflammation and fibrosis.
  • The study found that while all patients achieved sustained viral response, two later developed cancer, and a significant decrease in the GlycoFibroTest suggested liver inflammation improved, though it may not directly indicate reduced fibrosis.
View Article and Find Full Text PDF

The chytrid fungal pathogens Batrachochytrium dendrobatidis and Batrachochytrium salamandrivorans cause the skin disease chytridiomycosis in amphibians, which is driving a substantial proportion of an entire vertebrate class to extinction. Mitigation of its impact is largely unsuccessful and requires a thorough understanding of the mechanisms underpinning the disease ecology. By identifying skin factors that mediate key events during the early interaction with B.

View Article and Find Full Text PDF

Background: Coronavirus disease (COVID-19) is interfering heavily with the screening, diagnosis and treatment of cancer patients. Better knowledge of the seroprevalence and immune response after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in this population is important to manage them safely during the pandemic.

Methods: 922 cancer patients, 100 non-cancer patients and 94 health care workers (HCW) attending the Multidisciplinary Oncology Unit of Antwerp University Hospital from 24th of March 2020 till 31st of May 2020, and the Oncology Unit of AZ Maria Middelares Hospital, Ghent, from 13th of April 2020 till 31st of May 2020 participated in the study.

View Article and Find Full Text PDF

Background: Prediction of outcome after liver transplantation (LT) is limited by the lack of robust predictors of graft failure. In this prospective study, we aimed to define a serum glycomic signature in the first week after LT that is associated with graft loss at 3 mo after LT.

Methods: Patients were included between January 1, 2011, and February 28, 2017.

View Article and Find Full Text PDF

The outbreak of the SARS-CoV-2 pandemic has overwhelmed health care systems in many countries. The clinical presentation of the SARS-CoV-2 varies between a subclinical or flu-like syndrome to that of severe pneumonia with multi-organ failure and death. Initial reports have suggested that cancer patients may have a higher susceptibility to get infected by the SARS-CoV-2 virus but current evidence remains poor as it is biased by important confounders.

View Article and Find Full Text PDF

Glycosylation is an important post-translational modification, giving rise to a diverse and abundant repertoire of glycans on the cell surface, collectively known as the glycome. When focusing on immunity, glycans are indispensable in virtually all signaling and cell-cell interactions. More specifically, glycans have been shown to regulate key pathophysiological steps within T cell biology such as T cell development, thymocyte selection, T cell activity and signaling as well as T cell differentiation and proliferation.

View Article and Find Full Text PDF

For a long time, glycoprotein production has been limited by the inherent properties of production hosts. Glycosylation of biopharmaceuticals has been regarded as a necessary evil, often needed for protein folding or function, but also a source of heterogeneity, complicating downstream processing and product characterization. This has strongly determined the choice of production hosts.

View Article and Find Full Text PDF

Many pro-inflammatory pathways leading to arthritis have global effects on the immune system rather than only acting locally in joints. The reason behind the regional and patchy distribution of arthritis represents a longstanding paradox. Here we show that biomechanical loading acts as a decisive factor in the transition from systemic autoimmunity to joint inflammation.

View Article and Find Full Text PDF

Over the past 30 years, it has been firmly established that a wide spectrum of (autoimmune) diseases such as rheumatoid arthritis, Crohn's and lupus, but also other pathologies like alcoholic and non-alcoholic steatohepatitis (ASH and NASH) are driven by chronic inflammation and are hallmarked by a reduced level of serum IgG galactosylation. IgG (under)galactosylation is a promising biomarker to assess disease severity, and monitor and adjust therapy. However, this biomarker has not been implemented in routine clinical chemistry because of a complex analytical procedure that necessitates IgG purification, which is difficult to perform and validate at high throughput.

View Article and Find Full Text PDF

Human colony-stimulating factor 1 receptor (hCSF-1R) is unique among the hematopoietic receptors because it is activated by two distinct cytokines, CSF-1 and interleukin-34 (IL-34). Despite ever-growing insights into the central role of hCSF-1R signaling in innate and adaptive immunity, inflammatory diseases, and cancer, the structural basis of the functional dichotomy of hCSF-1R has remained elusive. Here, we report crystal structures of ternary complexes between hCSF-1 and hCSF-1R, including their complete extracellular assembly, and propose a mechanism for the cooperative human CSF-1:CSF-1R complex that relies on the adoption by dimeric hCSF-1 of an active conformational state and homotypic receptor interactions.

View Article and Find Full Text PDF

The HEK293 human cell lineage is widely used in cell biology and biotechnology. Here we use whole-genome resequencing of six 293 cell lines to study the dynamics of this aneuploid genome in response to the manipulations used to generate common 293 cell derivatives, such as transformation and stable clone generation (293T); suspension growth adaptation (293S); and cytotoxic lectin selection (293SG). Remarkably, we observe that copy number alteration detection could identify the genomic region that enabled cell survival under selective conditions (i.

View Article and Find Full Text PDF

Heterogeneity in the N-glycans on therapeutic proteins causes difficulties for protein purification and process reproducibility and can lead to variable therapeutic efficacy. This heterogeneity arises from the multistep process of mammalian complex-type N-glycan synthesis. Here we report a glycoengineering strategy--which we call GlycoDelete--that shortens the Golgi N-glycosylation pathway in mammalian cells.

View Article and Find Full Text PDF